Search

Hashem Farrokh

Examiner (ID: 13119, Phone: (571)272-4193 , Office: P/2131 )

Most Active Art Unit
2138
Art Unit(s)
2188, 2187, 2138, 2131, 2135
Total Applications
1256
Issued Applications
1101
Pending Applications
60
Abandoned Applications
119

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17426856 [patent_doc_number] => 20220054564 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-24 [patent_title] => SENECA VALLEY VIRUS (SVV) CELLULAR RECEPTOR TARGETED ONCOTHERAPY [patent_app_type] => utility [patent_app_number] => 17/406380 [patent_app_country] => US [patent_app_date] => 2021-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15344 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17406380 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/406380
Seneca valley virus (SVV) cellular receptor targeted oncotherapy Aug 18, 2021 Issued
Array ( [id] => 17542085 [patent_doc_number] => 11307202 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2022-04-19 [patent_title] => Antibody binding detection method for detecting MERS-CoV [patent_app_type] => utility [patent_app_number] => 17/406182 [patent_app_country] => US [patent_app_date] => 2021-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11487 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17406182 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/406182
Antibody binding detection method for detecting MERS-CoV Aug 18, 2021 Issued
Array ( [id] => 19778740 [patent_doc_number] => 12227764 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-02-18 [patent_title] => Pepmixes to generate multiviral CTLs with broad specificity [patent_app_type] => utility [patent_app_number] => 17/443261 [patent_app_country] => US [patent_app_date] => 2021-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 12703 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17443261 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/443261
Pepmixes to generate multiviral CTLs with broad specificity Jul 22, 2021 Issued
Array ( [id] => 18596052 [patent_doc_number] => 20230270843 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-31 [patent_title] => Post-Exposure Vaccination Against Viral Respiratory Infections [patent_app_type] => utility [patent_app_number] => 18/005780 [patent_app_country] => US [patent_app_date] => 2021-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13814 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18005780 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/005780
Post-Exposure Vaccination Against Viral Respiratory Infections Jul 13, 2021 Pending
Array ( [id] => 17201277 [patent_doc_number] => 20210341372 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-04 [patent_title] => METHOD OF QUANTITATIVE MEASUREMENT OF PARTICLE CONTENT USING HYDRATED STATE IMAGING [patent_app_type] => utility [patent_app_number] => 17/371143 [patent_app_country] => US [patent_app_date] => 2021-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3505 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17371143 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/371143
METHOD OF QUANTITATIVE MEASUREMENT OF PARTICLE CONTENT USING HYDRATED STATE IMAGING Jul 8, 2021 Abandoned
Array ( [id] => 19923189 [patent_doc_number] => 12297460 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2025-05-13 [patent_title] => Viral preparations and methods for treating and modulating mitochondrial effects of coronavirus infections [patent_app_type] => utility [patent_app_number] => 17/368994 [patent_app_country] => US [patent_app_date] => 2021-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5033 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17368994 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/368994
Viral preparations and methods for treating and modulating mitochondrial effects of coronavirus infections Jul 6, 2021 Issued
Array ( [id] => 18610919 [patent_doc_number] => 20230277649 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-07 [patent_title] => SWINE INFLUENZA A VIRUS VACCINE COMPRISING TWO DISTINCT RNA REPLICON PARTICLES [patent_app_type] => utility [patent_app_number] => 18/010412 [patent_app_country] => US [patent_app_date] => 2021-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19652 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18010412 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/010412
SWINE INFLUENZA A VIRUS VACCINE COMPRISING TWO DISTINCT RNA REPLICON PARTICLES Jun 17, 2021 Pending
Array ( [id] => 19014190 [patent_doc_number] => 11921114 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-03-05 [patent_title] => Systems and processes to screen for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) of 2019 (COVID-19) [patent_app_type] => utility [patent_app_number] => 17/337022 [patent_app_country] => US [patent_app_date] => 2021-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 3031 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 278 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17337022 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/337022
Systems and processes to screen for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) of 2019 (COVID-19) Jun 1, 2021 Issued
Array ( [id] => 17299523 [patent_doc_number] => 20210395362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-23 [patent_title] => CAR-T CELLS WITH HUMANIZED CD19 SCFV WITH MUTATION IN CDR 1 REGION [patent_app_type] => utility [patent_app_number] => 17/334417 [patent_app_country] => US [patent_app_date] => 2021-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8101 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17334417 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/334417
CAR-T cells with humanized CD19 ScFv with mutation in CDR 1 region May 27, 2021 Issued
Array ( [id] => 17256851 [patent_doc_number] => 20210369836 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-02 [patent_title] => SURFACE DISPLAY OF PROTEINS ON RECOMBINANT BACTERIA AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/330563 [patent_app_country] => US [patent_app_date] => 2021-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 64994 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17330563 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/330563
SURFACE DISPLAY OF PROTEINS ON RECOMBINANT BACTERIA AND USES THEREOF May 25, 2021 Abandoned
Array ( [id] => 19883468 [patent_doc_number] => 12269155 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-04-08 [patent_title] => Multivalent vaccines for rabies virus and coronaviruses [patent_app_type] => utility [patent_app_number] => 17/307066 [patent_app_country] => US [patent_app_date] => 2021-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 19 [patent_no_of_words] => 27496 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17307066 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/307066
Multivalent vaccines for rabies virus and coronaviruses May 3, 2021 Issued
Array ( [id] => 20563573 [patent_doc_number] => 12566179 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-03-03 [patent_title] => Coronavirus assays, diagnostic methods, treatment methods, and compositions related thereto [patent_app_type] => utility [patent_app_number] => 17/922670 [patent_app_country] => US [patent_app_date] => 2021-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 14 [patent_no_of_words] => 9560 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17922670 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/922670
Coronavirus assays, diagnostic methods, treatment methods, and compositions related thereto May 2, 2021 Issued
Array ( [id] => 17260033 [patent_doc_number] => 20210373018 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-02 [patent_title] => LATERAL FLOW DETECTION DEVICE FOR DETECTING A CORONAVIRUS BY IMMUNOASSAY [patent_app_type] => utility [patent_app_number] => 17/244129 [patent_app_country] => US [patent_app_date] => 2021-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17203 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17244129 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/244129
LATERAL FLOW DETECTION DEVICE FOR DETECTING A CORONAVIRUS BY IMMUNOASSAY Apr 28, 2021 Abandoned
Array ( [id] => 17201384 [patent_doc_number] => 20210341479 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-04 [patent_title] => QUANTITATIVE ANTIBODY TEST [patent_app_type] => utility [patent_app_number] => 17/243502 [patent_app_country] => US [patent_app_date] => 2021-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19366 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -128 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17243502 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/243502
Quantitative antibody test Apr 27, 2021 Issued
Array ( [id] => 17496522 [patent_doc_number] => 11285206 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-03-29 [patent_title] => Heat-resistant recombinant Newcastle Disease Virus vaccine strain capable of expressing truncated Fiber 2 protein of Fowl Adenovirus serotype 4, preparation method and application thereof [patent_app_type] => utility [patent_app_number] => 17/234795 [patent_app_country] => US [patent_app_date] => 2021-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 2532 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17234795 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/234795
Heat-resistant recombinant Newcastle Disease Virus vaccine strain capable of expressing truncated Fiber 2 protein of Fowl Adenovirus serotype 4, preparation method and application thereof Apr 19, 2021 Issued
Array ( [id] => 17227173 [patent_doc_number] => 20210353729 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-18 [patent_title] => NOVEL CANCER ANTIGENS AND METHODS [patent_app_type] => utility [patent_app_number] => 17/232597 [patent_app_country] => US [patent_app_date] => 2021-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30342 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17232597 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/232597
Cancer antigens and methods Apr 15, 2021 Issued
Array ( [id] => 17171718 [patent_doc_number] => 20210325388 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-21 [patent_title] => LATERAL FLOW DETECTION DEVICE FOR DETECTING A CORONAVIRUS BY IMMUNOASSAY [patent_app_type] => utility [patent_app_number] => 17/230302 [patent_app_country] => US [patent_app_date] => 2021-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14058 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17230302 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/230302
LATERAL FLOW DETECTION DEVICE FOR DETECTING A CORONAVIRUS BY IMMUNOASSAY Apr 13, 2021 Abandoned
Array ( [id] => 17050749 [patent_doc_number] => 20210260183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-26 [patent_title] => RAPID AND PROLONGED IMMUNOLOGIC-THERAPEUTIC [patent_app_type] => utility [patent_app_number] => 17/214885 [patent_app_country] => US [patent_app_date] => 2021-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26603 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17214885 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/214885
Rapid and prolonged immunologic-therapeutic Mar 27, 2021 Issued
Array ( [id] => 17120545 [patent_doc_number] => 11131672 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2021-09-28 [patent_title] => Method for detecting MERS-CoV in Camilidae [patent_app_type] => utility [patent_app_number] => 17/207063 [patent_app_country] => US [patent_app_date] => 2021-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11467 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17207063 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/207063
Method for detecting MERS-CoV in Camilidae Mar 18, 2021 Issued
Array ( [id] => 18467056 [patent_doc_number] => 20230201336 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-29 [patent_title] => INFLUENZA VIRUS-LIKE PARTICLES (VLPS) [patent_app_type] => utility [patent_app_number] => 17/996300 [patent_app_country] => US [patent_app_date] => 2021-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10240 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17996300 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/996300
INFLUENZA VIRUS-LIKE PARTICLES (VLPS) Mar 8, 2021 Pending
Menu